Florine Berger

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Predictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 26, 2021
Dynamics of the QTc interval over a 24-h dose interval after start of intravenous ciprofloxacin or low-dose erythromycin administration in ICU patients.

Florine A Berger, Willem van Weteringen, Heleen van der Sijs

|Mar 12, 2021
The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies.

Florine A Berger, Heleen van der Sijs, Teun van Gelder

|Jul 25, 2020
Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice.

Florine A Berger, Heleen van der Sijs, Matthijs L Becker

|Jun 14, 2019
Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose.

Florine A Berger, Midas B Mulder, Willemijn Ten Bosch-Dijksman

|Oct 24, 2017
QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.

Florine A Berger, Nico Monadian, Natasja M S de Groot

|Sep 20, 2017
Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording.

Florine Berger, Selma Saâïd, Teun van Gelder

Pageof 1

Frequent Collaborators

3 joint publications

Teun van Gelder

3 joint publications

Patricia van den Bemt

2 joint publications

Natasja M S de Groot

2 joint publications

Matthijs L Becker